Novartis (NVS) And CureVac (CVAC) Have Struck An Agreement To Produce Covid-19 Vaccine

CureVac (CVAC), a German biotechnology company, announced it had reached an agreement with Swiss giant Novartis (NVS) to support the vaccine’s production aimed against Covid-19 in 2021 using the company’s messenger mRNA that has been developed recently. According to an announcement by the German biotechnology company, Novartis plans to produce 50 million doses of the […]

Invest Headlines
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.